OpenAI Takes on Google With New AI Model Aimed at Drug Discovery
OpenAI is rolling out an early version of an artificial intelligence model meant to speed up drug discoveries, joining a field of growing interest for tech companies eager to prove AI can pave the way for more scientific breakthroughs.
Inference is becoming abundant. New evidence suggests the bigger economic and governance question is whether organizations can preserve independent judgment as machines shape more decisions.
Two critical PHP vulnerabilities triggered emergency government warnings and precautionary shutdowns on October 21. The deeper lesson lies in what happens between identifying a serious risk and having the authority and resources to fix it.
